> top > docs > PMC:7161517 > spans > 13808-14761 > annotations

PMC:7161517 / 13808-14761 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T78 199-203 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T79 234-249 Body_part denotes thoracic aortas http://purl.org/sig/ont/fma/fma3786
T80 442-456 Body_part denotes thoracic aorta http://purl.org/sig/ont/fma/fma3786
T81 662-678 Body_part denotes carotid arteries http://purl.org/sig/ont/fma/fma3939
T82 670-678 Body_part denotes arteries http://purl.org/sig/ont/fma/fma63812
T83 767-771 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T84 776-783 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T85 822-836 Body_part denotes arterial blood http://purl.org/sig/ont/fma/fma83066

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T41 234-249 Body_part denotes thoracic aortas http://purl.obolibrary.org/obo/UBERON_0001515
T42 372-378 Body_part denotes vessel http://purl.obolibrary.org/obo/UBERON_0000055
T43 442-456 Body_part denotes thoracic aorta http://purl.obolibrary.org/obo/UBERON_0001515
T44 451-456 Body_part denotes aorta http://purl.obolibrary.org/obo/UBERON_0000947
T45 822-836 Body_part denotes arterial blood http://purl.obolibrary.org/obo/UBERON_0013755
T46 831-836 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T61 79-82 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T131 53-60 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T132 163-164 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T133 234-249 http://purl.obolibrary.org/obo/UBERON_0001515 denotes thoracic aortas
T134 234-249 http://www.ebi.ac.uk/efo/EFO_0002525 denotes thoracic aortas
T135 372-378 http://purl.obolibrary.org/obo/UBERON_0000055 denotes vessel
T136 442-456 http://purl.obolibrary.org/obo/UBERON_0001515 denotes thoracic aorta
T137 442-456 http://www.ebi.ac.uk/efo/EFO_0002525 denotes thoracic aorta
T138 646-654 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T139 662-678 http://www.ebi.ac.uk/efo/EFO_0000818 denotes carotid arteries
T140 694-701 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T141 767-771 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T142 822-830 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T143 822-830 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T144 831-836 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T145 831-836 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T187 139-149 Chemical denotes olmesartan http://purl.obolibrary.org/obo/CHEBI_48416
T188 278-286 Chemical denotes atenolol http://purl.obolibrary.org/obo/CHEBI_2904|http://purl.obolibrary.org/obo/CHEBI_55352
T190 291-302 Chemical denotes hydralazine http://purl.obolibrary.org/obo/CHEBI_5775
T191 407-417 Chemical denotes olmesartan http://purl.obolibrary.org/obo/CHEBI_48416
T192 563-571 Chemical denotes atenolol http://purl.obolibrary.org/obo/CHEBI_2904|http://purl.obolibrary.org/obo/CHEBI_55352
T194 575-586 Chemical denotes hydralazine http://purl.obolibrary.org/obo/CHEBI_5775
T195 739-749 Chemical denotes olmesartan http://purl.obolibrary.org/obo/CHEBI_48416
T196 776-783 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T197 924-932 Chemical denotes atenolol http://purl.obolibrary.org/obo/CHEBI_2904|http://purl.obolibrary.org/obo/CHEBI_55352
T199 936-947 Chemical denotes hydralazine http://purl.obolibrary.org/obo/CHEBI_5775

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T93 0-93 Sentence denotes Similar upregulation of ACE2 was observed in studies focused on the effects of ARB treatment.
T94 94-357 Sentence denotes Spontaneously hypertensive rats treated with olmesartan demonstrated a 5-fold greater expression of ACE2 mRNA and increased Ang1-7 in their thoracic aortas, whereas those treated with atenolol and hydralazine exhibited no change in ACE2 expression or Ang1-7 (44).
T95 358-592 Sentence denotes Comparison of vessel wall dimensions showed that olmesartan selectively reduced the thoracic aorta media-to-lumen ratio, whereas vascular hypertrophy was unchanged in spontaneously hypertensive rats given atenolol or hydralazine (44).
T96 593-702 Sentence denotes There was no change in ACE2/Ang1-7 expression and/or activity in the carotid arteries of the treated animals.
T97 703-953 Sentence denotes The possibility that the effects of olmesartan on vascular ACE2 gene and protein expression were the result of reduced arterial blood pressure was ruled out because of the comparative effect observed in mice treated with atenolol or hydralazine (44).

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T525 24-28 G_3;PG_10;PR:000003622 denotes ACE2
T526 121-125 NCBITaxon:10114 denotes rats
T527 139-149 CHEBI:48416;CHEBI:48416 denotes olmesartan
T528 180-190 GO:0010467 denotes expression
T529 194-198 G_3;PG_10;PR:000003622 denotes ACE2
T530 218-222 PR:000036013 denotes Ang1
T531 234-249 UBERON:0001515 denotes thoracic aortas
T532 278-286 CHEBI:2904;CHEBI:2904 denotes atenolol
T533 291-302 CHEBI:5775;CHEBI:5775 denotes hydralazine
T534 326-330 G_3;PG_10;PR:000003622 denotes ACE2
T535 331-341 GO:0010467 denotes expression
T536 345-349 PR:000036013 denotes Ang1
T537 372-378 UBERON:0000055 denotes vessel
T538 379-383 UBERON:0000060 denotes wall
T539 442-456 UBERON:0001515 denotes thoracic aorta
T540 457-462 UBERON:0004363 denotes media
T541 552-556 NCBITaxon:10114 denotes rats
T542 563-571 CHEBI:2904;CHEBI:2904 denotes atenolol
T543 575-586 CHEBI:5775;CHEBI:5775 denotes hydralazine
T544 616-620 G_3;PG_10;PR:000003622 denotes ACE2
T545 621-625 PR:000036013 denotes Ang1
T546 628-638 GO:0010467 denotes expression
T547 662-678 UBERON:0005396 denotes carotid arteries
T548 694-701 NCBITaxon:33208 denotes animals
T549 762-766 G_3;PG_10;PR:000003622 denotes ACE2
T550 767-771 SO:0000704;GO:0010467 denotes gene
T551 776-783 BV_20 denotes protein
T552 784-794 BV_20;GO:0010467 denotes expression
T553 822-836 UBERON:0013755 denotes arterial blood
T554 906-910 NCBITaxon:10088 denotes mice
T555 924-932 CHEBI:2904;CHEBI:2904 denotes atenolol
T556 936-947 CHEBI:5775;CHEBI:5775 denotes hydralazine
T23650 64-68 G_3;PG_10;PR:000003622 denotes the
T20063 69-73 SO:0000704;GO:0010467 denotes ffec
T90002 78-85 BV_20 denotes ARB tr
T2173 86-96 BV_20;GO:0010467 denotes atment. Sp
T84173 124-138 UBERON:0013755 denotes s treated with
T25744 208-212 NCBITaxon:10088 denotes incr
T59010 226-234 CHEBI:2904;CHEBI:2904 denotes n their
T47013 238-249 CHEBI:5775;CHEBI:5775 denotes acic aortas
T34872 271-275 NCBITaxon:10114 denotes d wi
T53714 308-311 CHEBI:37886;CHEBI:37886;PR:000036009 denotes ite
T14892 312-314 PR:000036009 denotes n
T88568 331-334 CHEBI:37886;CHEBI:37886;PR:000036009 denotes exp
T25496 335-337 PR:000036009 denotes es
T6560 350-353 PR:000001251 denotes 7 (
T62928 378-381 PR:000001191 denotes wa
T35232 392-396 PR:000003622;G_3;PG_10 denotes ns s
T26354 407-418 UBERON:0001986 denotes olmesartan
T89670 419-430 CHEBI:16480;CHEBI:16480 denotes electively
T84189 440-450 GO:0010467 denotes e thoracic
T10845 473-477 PR:000001307 denotes atio
T1909 478-488 GO:0010467 denotes whereas v
T89580 522-526 NCBITaxon:10114 denotes in s
T30307 540-551 CHEBI:9434;CHEBI:9434 denotes ypertensive
T38415 586-590 G_3;PG_10;PR:000003622 denotes (44
T98868 604-615 UBERON:0001986 denotes o change in
T64155 616-627 CHEBI:16480;CHEBI:16480 denotes ACE2/Ang1-7
T75423 637-647 GO:0010467 denotes n and/or a
T30401 651-663 UBERON:0000948 denotes ity in the c
T13751 664-671 UBERON:0000055 denotes rotid a
T36514 676-691 UBERON:0002349 denotes es of the treat
T22953 724-734 GO:0010467 denotes the effect
T33050 742-745 PR:000001251 denotes esa
T74336 771-782 CHEBI:9434;CHEBI:9434 denotes and protei
T29878 798-806 GO:0016020 denotes e the re
T86770 807-811 PR:000001307 denotes ult
T46947 812-822 GO:0010467 denotes f reduced
T78149 835-863 PR:000000046 denotes d pressure was ruled out bec
T7543 873-883 GO:0010467 denotes e comparat
T19226 914-918 NCBITaxon:10114 denotes ated
T6758 929-944 UBERON:0001621 denotes lol or hydralaz

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
613 24-28 Gene denotes ACE2 Gene:59272
614 194-198 Gene denotes ACE2 Gene:302668
615 218-224 Gene denotes Ang1-7 Gene:305843
616 326-330 Gene denotes ACE2 Gene:302668
617 345-351 Gene denotes Ang1-7 Gene:305843
618 616-620 Gene denotes ACE2 Gene:302668
619 621-627 Gene denotes Ang1-7 Gene:305843
620 762-766 Gene denotes ACE2 Gene:70008
621 121-125 Species denotes rats Tax:10116
622 552-556 Species denotes rats Tax:10116
623 906-910 Species denotes mice Tax:10090
624 139-149 Chemical denotes olmesartan MESH:C437965
625 278-286 Chemical denotes atenolol MESH:D001262
626 291-302 Chemical denotes hydralazine MESH:D006830
627 407-417 Chemical denotes olmesartan MESH:C437965
628 563-571 Chemical denotes atenolol MESH:D001262
629 575-586 Chemical denotes hydralazine MESH:D006830
630 739-749 Chemical denotes olmesartan MESH:C437965
631 924-932 Chemical denotes atenolol MESH:D001262
632 936-947 Chemical denotes hydralazine MESH:D006830
633 108-120 Disease denotes hypertensive MESH:D006973
634 487-507 Disease denotes vascular hypertrophy MESH:D006984
635 539-551 Disease denotes hypertensive MESH:D006973

2_test

Id Subject Object Predicate Lexical cue
32305401-15833808-55252952 353-355 15833808 denotes 44
32305401-15833808-55252953 588-590 15833808 denotes 44
32305401-15833808-55252954 949-951 15833808 denotes 44